The CCL3/macrophage inflammatory protein-1α-binding protein evasin-1 protects from graft-versus-host disease but does not modify graft-versus- leukemia in mice

Journal of Immunology

Volumn 184, Issue 5, 2010, Pages 2646-2654

  Castor, Marina G M ^a   Rezende, Bárbara ^a   Resende, Carolina B ^a   Alessandri, Ana L ^a   Fagundes, Caio T ^a   Sousa, Lirlândia P ^a   Arantes, Rosa M E ^a   Souza, Danielle G ^a   Silva, Tarcília A ^a   Proudfoot, Amanda E I ^b   Teixeira, Mauro M ^a   Pinho, Vanessa ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b MERCK SERONO S A   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; EVASIN 1; GAMMA INTERFERON; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; RANTES; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; CCL3 PROTEIN, MOUSE; CCL5 PROTEIN, MOUSE; CHEMOKINE RECEPTOR; DEXAMETHASONE; EVASIN 1, RHIPICEPHALUS SANGUINEUS; EVASIN-1, RHIPICEPHALUS SANGUINEUS; MACROPHAGE INFLAMMATORY PROTEIN;

ACUTE GRAFT VERSUS HOST DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW TRANSPLANTATION; C57BL 6 MOUSE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ADHESION; CELL STRAIN HEK293; CELL TRANSPLANTATION; CONTROLLED STUDY; DISEASE SEVERITY; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LEUKOCYTE; LIVER INJURY; LYMPHOCYTIC INFILTRATION; MALE; MICROSCOPY; MORTALITY; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; SCORING SYSTEM; SMALL INTESTINE; WEIGHT REDUCTION; ANIMAL; C57BL MOUSE; CYTOLOGY; DBA MOUSE; DRUG EFFECT; FEMALE; GENETICS; IMMUNOLOGY; METABOLISM; MOUSE STRAIN; PATHOLOGY; SPLEEN; TRANSGENIC MOUSE;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL TRANSPLANTATION; CHEMOKINE CCL3; CHEMOKINE CCL5; DEXAMETHASONE; FEMALE; GRAFT VS HOST DISEASE; GRAFT VS LEUKEMIA EFFECT; IMMUNOHISTOCHEMISTRY; INTERFERON-GAMMA; INTESTINE, SMALL; MACROPHAGE INFLAMMATORY PROTEINS; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MICE, INBRED STRAINS; MICE, TRANSGENIC; RECEPTORS, CHEMOKINE; SPLEEN;

EID: 77951897445     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0902614     Document Type: Article

References (46)

1. Ferrara, J. L., and H. J. Deeg. 1991. Graft-versus-host disease. N. Engl. J. Med. 324: 667-674.
2. Krenger, W., G. R. Hill, and J. L. Ferrara. 1997. Cytokine cascades in acute graft-versus-host disease. Transplantation 27: 553-558. (Pubitemid 27377183)
3. Goker, H., I. C. Haznedaroglu, and N. J. Chao. 2001. Acute graft-vs-host disease: pathobiology and management. Exp. Hematol. 29: 259-277.
4. Will, A., and R. Wynn. 2006. Diagnosis of acute graft-versus-host disease. Transplantation 81: 505-506.
5. Howard, J. G., and M. F. A. Woodruff. 1961. Effect of the graft-versus-host reaction on the immunological responsiveness on the mouse. Proc. R. Soc. Lond. 154: 532-539.
6. Lapp, W. S., T. Ghayur, M. Mendes, M. Seddik, and T. A. Seemayer. 1985. The functional and histological basis for graft-versus-host-induced immunosuppression. Immunol. Rev. 88: 107-133.
7. Korngold, R., and J. Sprent. 1978. Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrow. J. Exp. Med. 148: 1687-1698.
8. Jaksch, M., and J. Mattsson. 2005. The pathophysiology of acute graft-versus-host disease. Scand. J. Immunol. 61: 398-409.
9. Wysocki, C. A., A. Panoskaltsis-Mortari, B. R. Blazar, and J. S. Serody. 2005. Leukocyte migration and graft-versus-host disease. Blood 105: 4191-4199.
10. Ferrara, J. L. 1993. Cytokine dysregulation as a mechanism of graft versus host disease. Curr. Opin. Immunol. 5: 794-799.
11. Hill, G. R., J. M. Crawford, K. R. Cooke, Y. S. Brinson, L. Pan, and J. L. Ferrara. 1997. Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines. Blood 90: 3204-3213. (Pubitemid 27444217)
12. + T cells to the liver, lung, and spleen during graft-versus-host disease. Blood 96: 2973-2980.
13. Serody, J. S., D. N. Cook, S. L. Kirby, E. Reap, T. C. Shea, and J. A. Frelinger. 1999. Murine T lymphocytes incapable of producing macrophage inhibitory protein-1 are impaired in causing graft-versus-host disease across a class I but not class II major histocompatibility complex barrier. Blood 93: 43-50. (Pubitemid 29019386)
14. Alcami, A. 2003. Viral mimicry of cytokines, chemokines and their receptors. Nat. Rev. Immunol. 3: 36-50.
15. Gillespie, R. D., M. L. Mbow, and R. G. Titus. 2000. The immunomodulatory factors of bloodfeeding arthropod saliva. Parasite Immunol. 22: 319-331.
16. Gillespie, R. D., M. C. Dolan, J. Piesman, and R. G. Titus. 2001. Identification of an IL-2 binding protein in the saliva of the Lyme disease vector tick, Ixodes scapularis. J. Immunol. 166: 4319-4326.
17. Frauenschuh, A., C. A. Power, M. Déruaz, B. R. Ferreira, J. S. Silva, M. M. Teixeira, J. M. Dias, T. Martin, T. N. Wells, and A. E. Proudfoot. 2007. Molecular cloning and characterization of a highly selective chemokine-binding protein from the tick Rhipicephalus sanguineus. J. Biol. Chem. 282: 27250-27258.
18. Déruaz, M., A. Frauenschuh, A. L. Alessandri, J. M. Dias, F. M. Coelho, R. C. Russo, B. R. Ferreira, G. J. Graham, J. P. Shaw, T. N. Wells, et al. 2008. Ticks produce highly selective chemokine binding proteins with antiinflammatory activity. J. Exp. Med. 205: 2019-2031.
19. Ferreira, B. R., and J. S. Silva. 1998. Saliva of Rhipicephalus sanguineus tick impairs T cell proliferation and IFN-γ-induced macrophage microbicidal activity. Vet. Immunol. Immunopathol. 64: 279-293.
20. Oliveira, C. J. F., K. A. Cavassani, D. D. Moré, G. P. Garlet, J. C. Aliberti, J. S. Silva, and B. R. Ferreira. 2008. Tick saliva inhibits the chemotactic function of MIP-1α and selectively impairs chemotaxis of immature dendritic cells by down-regulating cell-surface CCR5. Int. J. Parasitol. 38: 705-716.
21. Cook, D. N., M. A. Beck, T. M. Coffman, S. L. Kirby, J. F. Sheridan, I. B. Pragnell, and O. Smithies. 1995. Requirement of MIP-1α for an inflammatory response to viral infection. Science 269: 1583-1585.
22. Okabe, M., K. Kominami, and Y. Yoshimura. 1997. 'Green mice' as a source of ubiquitous green cells. FEBS Lett 407: 313-319.
23. Cooke, K. R., G. R. Hill, J. M. Crawford, D. Bungard, Y. S. Brinson, J. Delmonte, Jr., and J. L. Ferrara. 1998. Tumor necrosis factor- a production to lipopolysaccharide stimulation by donor cells predicts the severity of experimental acute graft-versus-host disease. J. Clin. Invest. 102: 1882-1891.
24. Colson, Y. L., K. Christopher, J. Glickman, K. N. Taylor, R. Wright, and D. L. Perkins. 2004. Absence of clinical GVHD and the in vivo induction of regulatory T cells after transplantation of facilitating cells. Blood 104: 3829-3835.
25. Thiele, D. L., M. L. Eigenbrodt, S. E. Bryde, E. H. Eigenbrodt, and P. E. Lipsky. 1989. Intestinal graft-versus-host disease is initiated by donor T cells distinct from classic cytotoxic T lymphocytes. J. Clin. Invest. 84: 1947-1956.
26. Barcelos, L. S., A. Talvani, A. S. Teixeira, G. D. Cassali, S. P. Andrade, and M. M. Teixeira. 2004. Production and in vivo effects of chemokines CXCL1-3/KC and CCL2/JE in a model of inflammatory angiogenesis in mice. Inflamm. Res. 53: 576-584.
27. Guy-Grand, D., and P. Vassalli. 1986. Gut injury in mouse graft-versus-host reaction. Study of its occurrence and mechanisms. J. Clin. Invest. 77: 1584-1595.
28. Piguet, P. F. 1985. GVHR I elicited by products of class or class II loci of the MHC: analysis of the response of mouse T lymphocytes to products of class I and class II loci of the MHC in correlation with GVHR-induced mortality, medullary aplasia, and enteropathy. J. Immunol. 135: 1637-1643.
29. El-Hayek, J. M., T. E. Rogers, and G. R. Brown. 2005. The role of TNF in hepatic histopathological manifestations and hepatic CD8+ T cell alloresponses in murine MHC class I disparate GVHD. J. Leukoc. Biol. 78: 1001-1007.
30. + T lymphocytes in the pathogenesis of liver injury in graft-versus-host disease. J. Clin. Invest. 104: 49-57.
31. Baker, M. B., N. H. Altman, E. R. Podack, and R. B. Levy. 1996. The role of cell-mediated cytotoxicity in acute GVHD after MHC-matched allogeneic bone marrow transplantation in mice. J. Exp. Med. 183: 2645-2656.
32. Zhang, Z. X., L. Yang, K. J. Young, B. Du Temple, and L. Zang. 2000. Identification of a previously unknown antigen-specific regulatory T cell and its mechanisms of suppression. Nat. Med. 6: 782-789.
33. Choi, S. W., G. C. Hildebrandt, K. M. Olkiewicz, D. A. Hanauer, M. N. Chaudhary, I. A. Silva, C. E. Rogers, D. T. Deurloo, J. M. Fisher, C. Liu, et al. 2007. CCR1/CCL5 (RANTES) receptor-ligand interactions modulate allogeneic T-cell responses and graft-versus-host disease following stem-cell transplantation. Blood 110: 3447-3455.
34. Lukacs, N. W. 2000. Migration of helper T-lymphocyte subsets into inflamed tissues. J. Allergy Clin. Immunol. 106(Suppl 5): 264-269.
35. Ward, S. G., K. Bacon, and J. Westwick. 1998. Chemokines and T lymphocytes: more than an attraction. Immunity 9: 1-11.
36. Schall, T. J., K. Bacon, K. J. Toy, and D. V. Goeddel. 1990. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature 347: 669-671.
37. Ellison, C. A., S. A. Natuik, A. R. McIntosh, S. A. Scully, D. M. Danilenko, and J. G. Gartner. 2003. The role of interferon-γ, nitric oxide and lipopolysaccharide in intestinal graft-versus-host disease developing in F1-hybrid mice. Immunology 109: 440-449.
38. Niederwieser, D., M. Herold, W. Woloszczuk, W. Aulitzky, B. Meister, H. Tilg, G. Gastl, R. Bowden, and C. Huber. 1990. Endogenous IFN-gamma during human bone marrow transplantation. Analysis of serum levels of interferon and interferon-dependent secondary messages. Transplantation 50: 620-625.
39. Ellison, C. A., J. M. Fischer, K. T. HayGlass, and J. G. Gartner. 1998. Murine graft-versus-host disease in an F1-hybrid model using IFN-γ gene knockout donors. J. Immunol. 161: 631-640.
40. Mowat, A. M. 1989. Antibodies to IFN-γ prevent immunologically mediated intestinal damage in murine graft-versus-host reaction. Immunology 68: 18-23.
41. Johnson, B. D., and R. L. Truitt. 1992. A decrease in graft-vs.-host disease without loss of graft-vs.-leukemia reactivity after MHC-matched bone marrow transplantation by selective depletion of donor NK cells in vivo. Transplantation 54: 104-112.
42. Johnson, B. D., W. R. Drobyski, and R. L. Truitt. 1993. Delayed infusion of normal donor cells after MHC-matched bone marrow transplantation provides an antileukemia reaction without graft-versus-host disease. Bone Marrow Transplant. 11: 329-336.
43. Johnson, B. D., C. McCabe, C. A. Hanke, and R. L. Truitt. 1995. Use of anti-CD3 epsilon F(ab′)2 fragments in vivo to modulate graft-versus-host disease without loss of graft-versus-leukemia reactivity after MHC-matched bone marrow transplantation. J. Immunol. 154: 5542-5554.
44. Johnson, B. D., E. E. Becker, and R. L. Truitt. 1999. Graft-vs.-host and graft-vs.-leukemia reactions after delayed infusions of donor T-subsets. Biol. Blood Marrow Transplant. 5: 123-132.
45. Johnson, B. D., N. Dagher, W. C. Stankowski, C. A. Hanke, and R. L. Truitt. 2001. Donor natural killer (NK1.1+) cells do not play a role in the suppression of GVHD or in the mediation of GVL reactions after DLI. Biol. Blood Marrow Transplant. 7: 589-595.
46. Xia, G., R. L. Truitt, and B. D. Johnson. 2006. Graft-versus-leukemia and graft-versus-host reactions after donor lymphocyte infusion are initiated by host-type antigen-presenting cells and regulated by regulatory T cells in early and longterm chimeras. Biol. Blood Marrow Transplant. 12: 397-407.